Abunidazole
- Level
- Commodity
- Parent
- 51302300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51302329This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6EH821150I. European Medicines Agency schedules Abunidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07364MIG. Abunidazole generally arises in the molecular formula C15H19N3O4. The term ABUNIDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) ABUNIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abunidazole under HS 29332990 and SITC 51573. As of Q4 2014, ABUNIDAZOLE remains the US FDA Preferred Term for this commodity. Abunidazole bears US NLM identifiers UMLS ID C2346715 and NCI Concept Code C73009. SMILES: OC(C1CC(C(C)(C)C)CCC1O)C1N(C([N](=O)O)CN1)C.
Same parent
Under 51302300 · 42Activities that produce or sell this
KBLI · 9Inherited from family 51300000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.